Cort
Phoenix Rising Founder
- Messages
- 7,383
I got the e-mail below from somebody and then sent it on to Dr. Light who'd mentioned propanolol in his presentation at the IACFS/ME. He gave a nice long response and permission to post it. It's interesting because as he notes theoretically they should not work in ME/CFS but in some patients they apparently work very well. (I believe some patients have the opposite effect)
I think this is really fascinating (albeit very difficult) field.
PATIENT
Just HAD to write about the idea about propanolol helping CFIDS/FM via Dr. Light's theory because I was totally disabled by CFIDS from 1984 to 1988. Typical story, tons of doctors, tests, clinics. No answer.
No life. A doctor did try propranolol for me but it didn't help much. Finally an endocrinologist took a wild stab at the idea of a tumor of the adrenal glands and gave me Normodyne (labetalol....a beta AND alpha blocker).
Ta da.......total cure!!! Up out of the bed after 4 years of hibernation - got married, had kids, etc.
I felt like I was cured for years. Then I couldn't get the name brand any more, and I slowly sank downward toward the pit again. The generic form seems to be missing something -but it's better than nothing I guess.
Of course all our cases are complex, there's no doubt about it. But I was SO EXCITED to hear that propanolol is being touted as a potential help - maybe the labetalol could help someone too - or better yet, the actual Normodyne if we could get out hands on the real stuff. None of the doctors have any idea why it worked that miracle for me - maybe Dr. Light's theory explains it - and if it does, then maybe there is indeed some hope!
Dr. Light
On Thu, Oct 8, 2009 at 9:21 AM, Alan Light <Alan.Light@hsc.utah.edu> wrote:
Here's a link to the paper I did on Dr. Light's presentation at the IACFS/ME Conference - "Surprise of the Conference". It was really exciting.
http://aboutmecfs.org/Conf/IACFS09Surprise.aspx
I think this is really fascinating (albeit very difficult) field.
PATIENT
Just HAD to write about the idea about propanolol helping CFIDS/FM via Dr. Light's theory because I was totally disabled by CFIDS from 1984 to 1988. Typical story, tons of doctors, tests, clinics. No answer.
No life. A doctor did try propranolol for me but it didn't help much. Finally an endocrinologist took a wild stab at the idea of a tumor of the adrenal glands and gave me Normodyne (labetalol....a beta AND alpha blocker).
Ta da.......total cure!!! Up out of the bed after 4 years of hibernation - got married, had kids, etc.
I felt like I was cured for years. Then I couldn't get the name brand any more, and I slowly sank downward toward the pit again. The generic form seems to be missing something -but it's better than nothing I guess.
Of course all our cases are complex, there's no doubt about it. But I was SO EXCITED to hear that propanolol is being touted as a potential help - maybe the labetalol could help someone too - or better yet, the actual Normodyne if we could get out hands on the real stuff. None of the doctors have any idea why it worked that miracle for me - maybe Dr. Light's theory explains it - and if it does, then maybe there is indeed some hope!
Dr. Light
On Thu, Oct 8, 2009 at 9:21 AM, Alan Light <Alan.Light@hsc.utah.edu> wrote:
Cort, yes we (actually the smarter of the two Dr. Light’s here in Utah, my wife, Dr. Kathleen Light) had actually thought that labetalol might be of more use in at least some of the CFS patients. This was because we did see that in at least some patients, there was a substantial increase in baseline levels of alpha receptors and a substantial increase in them caused by exercise. This is different than the beta receptors where the baseline levels are lower, but similar in respect to the increases following exercise.
The reason that Normodyne may have been more effective than generics could be because it is slightly different in the ratio of beta vs alpha inhibition, or it could simply be a dose effect.
Theoretically, beta and alpha blockers should actually make CFS patients worse, because the prevailing theory (with some pretty good evidence) is that vascular smooth muscle alpha and beta receptors are DOWN regulated (are effectively non-functional) due to an “overdrive” of the sympathetic nervous system.
Activation of these receptors is essential for proper control of blood flow in skeletal muscles and perhaps also the brain. Without proper control, the amount of metabolites signaling fatigue and muscle pain could swing wildly, leading to the sensation of fatigue with even modest movement, and even at rest. Worse, it could lead to orthostatic hypotension (a very common symptom in CFS patients) that could cause the patient to faint when standing, or even sitting upright. So high doses of lebetalol would seem to be contraindicated in CFS.
What we found is that there are also alpha and beta receptors on both the muscle sensory neurons that signal fatigue and also those that signal muscle pain, as well as on circulating immune cells. We further found that the receptors on the sensory neurons and immune cells were blocked at lower doses (1 tenth the dose) than is necessary to block alpha and beta receptors on vascular smooth muscle.
This means that low doses of propranolol (again 1/5 to 1/10 the dose that is prescribed for blood pressure control) can block the sensory receptors, reducing the total signal to the sympathetic nervous system, allowing the normal sympathetic reflexes to be re-established, leading to much more normal control of metabolite levels in muscle and brain.
(Much of this last section is still speculation—only inferred from the data we have on blood pressure and vascular control in FM patients, published in Adrenergic dysregulation and pain with and without acute beta-blockade in women with fibromyalgia and temporomandibular disorder. Light KC, Bragdon EE, Grewen KM, Brownley KA, Girdler SS, Maixner W.J Pain. 2009 May;10(5):542-52.).
Anyway, what this means is that the patient who responded to labetalol may have failed with propranolol because the dose give was too high, or because he really did need the additional alpha adrenergic blockade. He may be failing with generic labetalol because the dose prescribed is higher than previously given (the prescribing physician almost certainly doesn’t know the info above) either because he believed more is better, or because the generic is more potent, or the generic could be failing because it has a different profile in its alpha vs beta inhibition. I’d suggest the patient try varying his dose downward, because this is one case where a LOWER dose might actually be much more effective than a higher dose.
Another possibility is that the patient’s dysregulation has shifted and no longer is due to the alpha-beta receptor dysregulation. We hope to figure these sorts of things out with our current research aimed at looking at treatment effects on dysregulation of the genes that control and signal fatigue.
Here's a link to the paper I did on Dr. Light's presentation at the IACFS/ME Conference - "Surprise of the Conference". It was really exciting.
http://aboutmecfs.org/Conf/IACFS09Surprise.aspx